StreetInsider.com
  • Log-In
  • |
  • Home
  • |
  • E-mail Alerts
  • |
  • My Headlines
  • |
  • Portfolio


  • Home
  • Menu
    • JOIN
    • SI Premium
    • Ratings
    • Mergers
    • Earnings
    • Dividends
    • IPOs
    • Hedge Funds
    • Premium Letters
    • Send a Tip
    • API/Data
  • JOIN
  • SI Premium
    • Full Feed View
    • Headline View
    • SI Premium Squawk Box
    • Alerts
    • Custom Headlines
    • Upgrade Your Current Account
    • API
  • Calendars
    • Co. NDR/Event Calendar
    • Dividend Calendar
    • Earnings Calendar
    • Event Driven
    • FDA Calendar
    • Investor Conferences
    • IPO Calendar
    • Merger Arb
    • Ratings Calendar
    • Stock Split Calendar
  • Ratings
    • Analyst Comments
    • Hot Analyst Comments
    • Analyst EPS Change
    • Analyst EPS View
    • Analyst PT Change
    • Credit Ratings
    • Downgrade News
    • Hot Downgrades
    • New Coverage News
    • Hot New Coverage
    • Upgrade News
    • Hot Upgrades
    • More...
  • Mergers
    • Merger News
    • Hot M&A News
    • Private Equity
    • Rumors
    • SPAC News
    • Spinoffs
    • Merger Arbitrage
    • Event Driven
    • 2021 Top M&A Deals
    • Top 50 Takeover Targets
    • More...
  • Earnings
    • Earnings Calendar
    • Earnings News
    • Hot Earnings
    • Guidance
    • Hot Guidance
    • Conference Calls
    • Earnings History Search
    • More...
  • Dividends
    • Dividend Calendar
    • Dividend News
    • Hot Dividends
    • Dividend Hike
    • Special Dividends
    • Stock Buybacks
    • Hot Stock Buybacks
    • Stock Splits
    • More...
  • IPOs
    • IPO News
    • Hot IPOs
    • Equity Offerings
    • Recent IPOs
    • Upcoming IPOs
    • 2021 Top IPOs
    • More...
  • Hedge Funds
    • 13D
    • 13F
    • 13G
    • Hedge Funds News
    • Hot Insider Trades
    • Insider Trades
    • More...
  • Premium Letters
    • Pulse Picks
    • Stealth Growth Insider
  • Send a Tip
  • API/Data
  • QUICK LINKS :
  • Goldman Sachs Conviction Buy List
  • Warren Buffett News
  • Elliott Management News
  • Follow @Street_Insider

Five Prime Therapeutics (FPRX) Tops Q3 EPS by 6c

Article Related Press Releases (1) Related Articles (1) Related SEC Filings (1) Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. CSQR
2. B
3. STDN
4. SPY
5. RHP
6. IPH
7. TTWO
8. SLN
9. IPHA
10. TZOO

Top News Most Read Special Reports
  • S&P 500, Nasdaq futures inch up as markets monitor Hormuz situation
  • JPMorgan lifts S&P 500 target to 8,000 on strong earnings
  • Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
  • Oil edges higher as Iran tempers hopes of swift Hormuz reopening
  • HPE stock surges 5% as Morgan Stanley upgrades, pointing to ~30% upside
  • Intel (INTC) files for proposed share offering
  • SpaceX retail investors turn sellers for first time since IPO
  • After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
  • After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
  • After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
  • After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
  • After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Go back to Five Prime Therapeutics (FPRX) Tops Q3 EPS by 6c

Form 8-K FIVE PRIME THERAPEUTICS For: Nov 04

November 4, 2015 4:19 PM EST

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More

 
Free News Feed
Get our RSS Feed!
© Copyright 2026 StreetInsider.com
Home
Member's Home
Premium Content
Links
Entities
About StreetInsider
Get Our Content
Advertise with Us
Contact Us
Disclaimer
Privacy Policy
Do Not Sell My Information